InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,634.80
(
0.80%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.91
(
0.54%
)
Bitcoin
60,286.10
(
-2.81%
)
Post# of 252476
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rfj1862

Send PM Follow Ignore
Followers 39
Posts 1714
Boards Moderated 0
Alias Born 10/05/2005

rfj1862

Re: DewDiligence post# 50565

Friday, 08/03/2007 3:00:17 PM

Friday, August 03, 2007 3:00:17 PM

Post# of 252476
I haven't done a detailed analysis of Amgen from an investment standpoint, but I can say that their pipeline is impressive, particularly in oncology and osteoporosis. I suspect denosumab will become a mega-blockbuster in osteoporosis, particularly with the concerns surrounding bisphosphonates regarding osteonecrosis of the jaw. Justifiable or not.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up